Can you provide a treatment algorithm, preferably in diagram form, for managing solar lentigo and melasma?

Treatment Algorithm for Solar Lentigo and Melasma

Solar Lentigo Treatment Algorithm

For solar lentigines, laser therapy—particularly intense pulsed light (IPL) or pulsed dye laser—represents the most effective first-line treatment, with topical stabilized cysteamine as an alternative for patients preferring non-procedural approaches.

Step 1: Initial Assessment

• Confirm diagnosis clinically (well-demarcated brown macules on sun-exposed areas)
• Document Fitzpatrick skin type (critical for laser parameter selection)
• Assess lesion location, size, and patient expectations

Step 2: Treatment Selection

Primary Option - Laser/Light-Based Therapy:

• Intense Pulsed Light (500-635 nm): 74.6%-90% efficacy, single treatment often sufficient 1, 2

  • Delivers pulses through targeted tip until mild swelling and gray color observed
  • Minimal downtime (erythema resolves within 5 hours)
  • Lowest risk of post-inflammatory hyperpigmentation

• Pulsed Dye Laser: 27%-57% success rate 3, 2

  • Can use single stacked pulse or two sessions 1 month apart
  • Excellent safety profile in Fitzpatrick III-IV skin

• Picosecond Laser: 67.9%-93.02% efficacy 2

  • Highest success rates among laser modalities

Alternative Option - Topical Therapy:

• Stabilized Cysteamine Cream: Daily application for 12 weeks 4
  • 40% reduction in pigmentation (p < 0.002)
  • First truly effective topical therapy for solar lentigines
  • Ideal for patients declining procedures or with multiple lesions

Third-Line Options:

• High-Intensity Macro-Focused Ultrasound (HI-MFU): Emerging option with added skin tightening benefits 5
• Cryotherapy: 37%-71.4% success but higher risk of severe adverse events 2
• Chemical Peels (TCA): 12%-46% efficacy, generally less effective 2

Step 3: Post-Treatment Management

• Strict photoprotection (critical to prevent recurrence)
• Monitor for recurrence at 3-6 months
• Repeat treatment if needed

---

Melasma Treatment Algorithm

Melasma requires a chronic disease management approach combining topical depigmenting agents as foundation therapy, with procedural interventions (particularly PRP or tranexamic acid injections) reserved for refractory cases, always coupled with rigorous photoprotection.

Step 1: Baseline Assessment

• Establish mMASI score for objective monitoring 6
• Identify triggers (UV exposure, hormonal factors)
• Set realistic expectations (chronic condition requiring maintenance)

Step 2: Foundation Therapy (ALL Patients)

Topical Regimen:

• Triple combination: Hydroquinone + Tretinoin + Corticosteroids 6
• Alternative agents: Tranexamic acid, azelaic acid, kojic acid
• Duration: Minimum 8-12 weeks for initial response
• Maintenance: Ongoing daily application required

Essential Adjunct:

• Strict photoprotection: Broad-spectrum SPF 50+ daily, reapplication every 2 hours
• Home care routine: Non-negotiable for treatment success 6

Step 3: Procedural Interventions (For Inadequate Response)

Preferred Injectable Option:

• Platelet-Rich Plasma (PRP): 6
  • Significant mMASI reduction demonstrated in multiple RCTs
  • Superior efficacy to tranexamic acid injections in most studies
  • Protocol: 3 treatments minimum, 21-day intervals
  • Maintenance: Every 6 months thereafter
  • Combine with topical agents for synergistic effect
  • Microneedling delivery more effective than intradermal injection 6

Alternative Injectable:

• Tranexamic Acid Injections: Effective but generally less so than PRP 6
  • Consider when PRP unavailable or cost-prohibitive

Step 4: Maintenance Phase (Lifelong)

Critical Pitfall to Avoid: Treating melasma as an acute condition rather than chronic disease leads to treatment failure and patient dissatisfaction 6.

• Continue daily topical maintenance therapy
• Maintain strict photoprotection indefinitely
• Regular follow-up every 3-6 months
• Repeat procedural interventions as needed (typically every 6 months)

---

Key Clinical Pearls

For Solar Lentigines:

• IPL and picosecond lasers offer highest efficacy with best safety profiles 1, 2
• Stabilized cysteamine represents breakthrough in topical therapy—40% improvement versus 2% with vehicle 4
• Single treatment often sufficient with laser, unlike melasma

For Melasma:

• Manage as chronic condition from outset 6
• PRP shows consistent mMASI reduction across multiple RCTs 6
• Combination therapy (topical + procedural + photoprotection) superior to monotherapy
• Patient compliance with photoprotection determines long-term success

Common Pitfall: Confusing lentigo maligna (melanoma in situ requiring complete excision) with benign solar lentigines 7, 8. Lentigo maligna requires biopsy confirmation and surgical excision with clear margins, not cosmetic treatments.